Current highlights

  1. Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates

    Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates

    Abstract Full Text Full Text PDF (362 KB) Patient Summary
  2. Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer

    Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer

    Abstract Full Text Full Text PDF (780 KB) Patient Summary
  3. The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study eulogo1

    The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study

    Abstract Full Text Full Text PDF (268 KB) Patient Summary
  4. The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis

    The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis

    Abstract Full Text Full Text PDF (1,9 MB) Patient Summary
  5. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens eulogo1

    Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Abstract Full Text Full Text PDF (1,2 MB) Patient Summary

Hot off the press

  1. Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative

    Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative

    Abstract Full Text Full Text PDF (814 KB)
    Corrected
  2. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score

    Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score

    Abstract Full Text Full Text PDF (404 KB)
    Corrected
  3. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned

    More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned

    Abstract Full Text Full Text PDF (415 KB)
    Corrected